These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 16218420

  • 41. Mesalazine interstitial nephritis presenting as colitis ulcerosa exacerbation.
    Van Biervliet S, Raes A, Vande Walle J, Van Winckel M, Robberecht E, Praet M.
    Acta Gastroenterol Belg; 2006; 69(3):321-2. PubMed ID: 17168131
    [Abstract] [Full Text] [Related]

  • 42. Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis.
    Fleming K, Ashcroft A, Alexakis C, Tzias D, Groves C, Poullis A.
    World J Gastroenterol; 2015 Mar 21; 21(11):3376-9. PubMed ID: 25805947
    [Abstract] [Full Text] [Related]

  • 43. [Mesalazine-induced eosinophilic pneumonia in a patient with Crohn's disease].
    Park JE, Hwangbo Y, Chang R, Chang YW, Jang JY, Kim BH, Dong SH, Kim HJ.
    Korean J Gastroenterol; 2009 Feb 21; 53(2):116-20. PubMed ID: 19237838
    [Abstract] [Full Text] [Related]

  • 44. Mesalamine-induced pleuritis in a patient with ulcerative colitis.
    Tozzi A, Biagini MR, Rastelli C, Galli A, Baldi D, Milani S.
    Inflamm Bowel Dis; 2009 Jan 21; 15(1):158-9. PubMed ID: 18629902
    [No Abstract] [Full Text] [Related]

  • 45. [Mesalazine granules instead of tablets. New ulcerative colitis therapy confirmed also in general practice routine].
    MMW Fortschr Med; 2004 Jun 10; 146(24):53. PubMed ID: 15366501
    [No Abstract] [Full Text] [Related]

  • 46. Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitis.
    Gibson PR, Fixa B, Pekárková B, Bátovský M, Radford-Smith G, Tibitanzl J, Gabalec L, Florin TH, Greinwald R.
    Aliment Pharmacol Ther; 2006 Apr 01; 23(7):1017-26. PubMed ID: 16573804
    [Abstract] [Full Text] [Related]

  • 47. [Renal involvement in patients with chronic inflammatory intestinal disease treated with mesalazine. How to prevent its nephrotoxicity?].
    Bonet J, Vaquero M, Bayés B, Romero R.
    Med Clin (Barc); 1999 Jul 10; 113(5):199. PubMed ID: 10480148
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.
    Miner PB, Wedel MK, Xia S, Baker BF.
    Aliment Pharmacol Ther; 2006 May 15; 23(10):1403-13. PubMed ID: 16669955
    [Abstract] [Full Text] [Related]

  • 50. Mesalazine-induced multi-organ hypersensitivity.
    Sposato B, Allegri MP, Riccardi MP, Chigiotti S, Nencioni C, Ricciardi B, Carli T, Cresti A, Perari MG, Migliorini MG, Toti M.
    Clin Drug Investig; 2010 May 15; 30(6):413-7. PubMed ID: 20441247
    [Abstract] [Full Text] [Related]

  • 51. Pulmonary pathology in patients with ulcerative colitis treated with mesalazine--a challenging and complex diagnostic problem. Case series and literature review.
    Kacprzak A, Siemion-Szcześniak I, Szturmowicz M, Bestry I, Langfort R, Kuś J.
    Pneumonol Alergol Pol; 2014 May 15; 82(4):368-76. PubMed ID: 24964241
    [Abstract] [Full Text] [Related]

  • 52. Mesalazine and photosensitivity.
    Horiuchi Y, Shimakura S.
    Am J Gastroenterol; 1999 Nov 15; 94(11):3386-7. PubMed ID: 10566765
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Budesonide foam as a new therapeutic principle in distal ulcerative colitis in comparison with mesalazine enema. An open, controlled, randomized and prospective multicenter pilot study].
    Rufle W, Frühmorgen P, Huber W, Kimmig JM.
    Z Gastroenterol; 2000 Apr 15; 38(4):287-93. PubMed ID: 10820860
    [Abstract] [Full Text] [Related]

  • 55. Drug-induced hypersensitivity syndrome with lupus manifestations due to mesalazine in a patient with ulcerative colitis.
    Zgheib O, Trombert V, Jandus P, Serratrice C.
    BMJ Case Rep; 2022 Feb 25; 15(2):. PubMed ID: 35217557
    [Abstract] [Full Text] [Related]

  • 56. Pleural effusion in temporal arteritis.
    Karachalios G, Charalabopoulos A, Charalabopoulos K.
    In Vivo; 2003 Feb 25; 17(2):151-2. PubMed ID: 12792976
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.